selected publications
- Novel genetically engineered mouse models for clear cell renal cell carcinoma. Scientific reports. 2023 Academic Article GET IT
-
Combined whole-organ imaging at single-cell resolution and immunohistochemical analysis of prostate cancer and its liver and brain metastases.
Cell reports.
2021
Academic Article
GET IT
Times cited: 1 -
The PHLPP2 phosphatase is a druggable driver of prostate cancer progression.
The Journal of cell biology.
2019
Academic Article
GET IT
Times cited: 22 -
Utility of Single-Cell Genomics in Diagnostic Evaluation of Prostate Cancer.
Cancer research.
2017
Academic Article
GET IT
Times cited: 20 -
Rapid and tunable method to temporally control gene editing based on conditional Cas9 stabilization.
Nature communications.
2017
Academic Article
GET IT
Times cited: 109 -
The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN protein.
The Journal of cell biology.
2017
Academic Article
GET IT
Times cited: 28 -
Plasma ghrelin and interleukin-6 levels correlate with body mass index and arterial blood pressure in males with essential hypertension.
Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
2015
Academic Article
GET IT
Times cited: 18 -
MYC Drives Pten/Trp53-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2.
Cancer discovery.
2015
Academic Article
GET IT
Times cited: 55 -
Pleckstrin homology domain leucine-rich repeat protein phosphatases set the amplitude of receptor tyrosine kinase output.
Proceedings of the National Academy of Sciences of the United States of America.
2014
Academic Article
GET IT
Times cited: 26 -
Molecular pathways: PI3K pathway phosphatases as biomarkers for cancer prognosis and therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research.
2014
Academic Article
GET IT
Times cited: 26 -
Prostate cancer genetic-susceptibility locus on chromosome 20q13 is amplified and coupled to androgen receptor-regulation in metastatic tumors.
Molecular cancer research : MCR.
2013
Academic Article
GET IT
Times cited: 6 -
WT1 mutants reveal SRPK1 to be a downstream angiogenesis target by altering VEGF splicing.
Cancer cell.
2011
Academic Article
GET IT
Times cited: 196 -
Identification of PHLPP1 as a tumor suppressor reveals the role of feedback activation in PTEN-mutant prostate cancer progression.
Cancer cell.
2011
Academic Article
GET IT
Times cited: 135 -
Overexpression of VEGF165b in podocytes reduces glomerular permeability.
Journal of the American Society of Nephrology : JASN.
2010
Academic Article
GET IT
Times cited: 36 -
Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes.
BMC cancer.
2010
Academic Article
GET IT
Times cited: 44 -
Regulation of vascular endothelial growth factor (VEGF) splicing from pro-angiogenic to anti-angiogenic isoforms: a novel therapeutic strategy for angiogenesis.
The Journal of biological chemistry.
2009
Academic Article
GET IT
Times cited: 176 -
Expression of pro- and anti-angiogenic isoforms of VEGF is differentially regulated by splicing and growth factors.
Journal of cell science.
2008
Academic Article
GET IT
Times cited: 275 -
Morphological parameters of the angiogenic response in pancreatic ductal adenocarcinoma--correlation with histological grading and clinical data.
Folia histochemica et cytobiologica.
2001
Academic Article
GET IT
Times cited: 9